Literature DB >> 25551958

Premature ovarian failure: diagnosis and treatment.

R Slopień1, A Warenik-Szymankiewicz.   

Abstract

Premature ovarian failure (POF), also known as primary ovarian insufficiency, is diagnosed in the event when primary or secondary amenorrhea and hypoestrogenism with high levels of gonadotropins occur in women before the age of 40. POF, caused by genetic, autoimmune and environmental factors, leads to a decrease in numbers of primordial follicles, accelerated atresia, and impaired follicular function. The diagnosis of POF is an indication for hormonal replacement therapy (HRT), which should be continued until the mean age of menopause in a given population. HRT reduces the intensity of vasomotor symptoms and has a beneficial effect on the central nervous, skeletal, cardiovascular, and urinary-reproductive systems.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25551958

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  4 in total

1.  Follicle inhibition at the primordial stage without increasing apoptosis, with a combination of everolimus, verapamil.

Authors:  Michail Pargianas; Ioannis Kosmas; Kyriaki Papageorgiou; Chrysoula Kitsou; Alexandra Papoudou-Bai; Anna Batistatou; Sofia Markoula; Styliani Salta; Alexandros Dalkalitsis; Stratis Kolibianakis; Basil C Tarlatzis; Ioannis Georgiou; Theologos M Michaelidis
Journal:  Mol Biol Rep       Date:  2020-10-20       Impact factor: 2.316

Review 2.  Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure.

Authors:  Oldouz Shareghi-Oskoue; Leili Aghebati-Maleki; Mehdi Yousefi
Journal:  Stem Cell Res Ther       Date:  2021-08-11       Impact factor: 8.079

Review 3.  MicroRNAs in ovarian function and disorders.

Authors:  Ying Li; Ying Fang; Ying Liu; Xiaokui Yang
Journal:  J Ovarian Res       Date:  2015-08-01       Impact factor: 4.234

4.  Establishment of Effective Mouse Model of Premature Ovarian Failure Considering Treatment Duration of Anticancer Drugs and Natural Recovery Time.

Authors:  Eun Hee Lee; Si Eun Han; Min Jung Park; Hyeon Jung Kim; Hwi Gon Kim; Chang Woon Kim; Bo Sun Joo; Kyu Sup Lee
Journal:  J Menopausal Med       Date:  2018-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.